KR20150126215A - A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof - Google Patents

A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof Download PDF

Info

Publication number
KR20150126215A
KR20150126215A KR1020140053609A KR20140053609A KR20150126215A KR 20150126215 A KR20150126215 A KR 20150126215A KR 1020140053609 A KR1020140053609 A KR 1020140053609A KR 20140053609 A KR20140053609 A KR 20140053609A KR 20150126215 A KR20150126215 A KR 20150126215A
Authority
KR
South Korea
Prior art keywords
yeast
component
supernatant
extract
distilled water
Prior art date
Application number
KR1020140053609A
Other languages
Korean (ko)
Inventor
김영실
추동원
박정은
이혜진
김진휘
Original Assignee
주식회사 티아라줄기세포연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 티아라줄기세포연구소 filed Critical 주식회사 티아라줄기세포연구소
Priority to KR1020140053609A priority Critical patent/KR20150126215A/en
Publication of KR20150126215A publication Critical patent/KR20150126215A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a therapeutic agent for alopecia using a yeast extract, and a method for manufacturing the same and, more specifically, to a therapeutic agent for alopecia manufactured by using beer yeasts or raw rice wine (makgeolli) yeasts, and a method for manufacturing the same. The therapeutic agent for alopecia using the yeast extract of the present invention contains more than one yeast component among the beer yeasts and the makgeolli yeasts. In addition, the method for manufacturing the therapeutic agent for alopecia using the yeast extract comprises: a first step of fermenting yeasts in a medium; a second step of centrifuging the yeasts and the medium, and removing a supernatant, and then separating the yeast component from sediment; a third step of removing aqueous smell components by washing the yeast component from the second step with distilled water; a fourth step of centrifuging the yeast component from the third step, and removing the supernatant; a fifth step of removing alcohol-soluble smell components by washing the yeast component from the fourth step with alcohol; a sixth step of centrifuging the yeast component from the fifth step, and removing the supernatant; a seventh step of swelling yeast cells by dispersing the yeast component from the sixth step in distilled water; an eighth step of lysing the yeast cells from the seventh step so as to diffuse the yeast cells and a lysate thereof in the distilled water; a ninth step of centrifuging the distilled water from the eighth step, and removing non-aqueous sediment, and then collecting an aqueous supernatant; a tenth step of sterilizing the aqueous supernatant so as to remove microorganisms capable of causing decomposition; and an eleventh step of manufacturing the yeast extract by freezing or lyophilizing the aqueous supernatant from the tenth step.

Description

효모성분추출물을 이용한 탈모치료제 및 이의 제조방법{A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof}[0001] The present invention relates to a pharmaceutical agent for alopecia and a method for producing the same,

본 발명은 효모성분추출물을 이용한 탈모치료제 및 이의 제조방법에 관한 것으로, 더욱 상세하게는 맥주 효모 또는 막걸리 효모성분을 이용하여 제조된 탈모치료제 및 이의 제조방법에 관한 것이다.The present invention relates to a hair loss therapeutic agent using a yeast component extract and a method for preparing the same, and more particularly, to a hair loss treatment agent prepared using a brewer's yeast or a makgeolli yeast ingredient and a method for producing the same.

최근 삶의 질이 향상됨에 따라 미용에 대한 관심도가 지나칠 정도로 높아지고 있으며 이에 따라 화장품, 비누, 영양제, 그밖에 탈모치료제 등 유효한 피부용약재 또한 이들을 화장품 또는 비누 등의 첨가한 미용제들을 경쟁적으로 선택사용하고 있는 실정이다.As the quality of life has improved recently, interest in cosmetics has been excessively increased. Accordingly, effective skin-care medicines such as cosmetics, soaps, nutritional supplements, and hair loss remedies have also been used in cosmetics or cosmetics, It is true.

그러나 상기와 같은 미용제 또는 치료제를 사용중에 피부의 손상이나 부작용을 일으키는 사례가 발생되고 있으며 이와 같은 사례는 천연재료를 첨가한 미용제보다 속효성의 화학합성제가 첨가된 미용제를 사용함에 따른 부작용의 빈도가 크다 할 수 있다.However, there have been cases in which skin damage or side effects are caused during use of the cosmetic agent or therapeutic agent as described above. In this case, the use of a cosmetic agent containing a chemical agent having a quicker effect than a natural agent- The frequency can be high.

종래의 기술에서 탈모치료제 또는 피부치료제를 제조할 때는 일반적으로 효과를 증진시키기 위해 화학성분을 첨가하는 데, 이러한 화학성분을 과도하게 사용할 경우 두피를 더욱 건조하게 하거나 두피를 자극하게 되는 문제점이 있다.In the conventional art, when a hair loss therapeutic agent or a skin treatment agent is produced, a chemical ingredient is generally added to enhance the effect. When such a chemical ingredient is used excessively, there is a problem that the scalp becomes more dry or stimulates the scalp.

한국등록특허 제 10-0822028 호Korean Patent No. 10-0822028

본 발명에서는 상술한 문제점을 해결하기 위한 것으로, 본 발명의 목적은 맥주 효모 또는 막걸리 효모를 이용하여 냄새와 침전물이 없는 효모성분추출물을 제조하며, 이를 탈모치료제로 사용함으로써 인체에 부작용이 없는 우수한 탈모치료제를 제공하는 것이다.The object of the present invention is to solve the above-mentioned problems, and an object of the present invention is to provide a yeast extract having no odor and sediment by using brewer's yeast or rice wine yeast, Thereby providing a therapeutic agent.

발명이 해결하고자 하는 기술적 과제들은 이상에서 언급한 기술적 과제들로 제한되지 않으며, 언급되지 않은 또 다른 기술적 과제들은 아래의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are not restrictive of the invention as set forth in the accompanying drawings. It will be possible.

본 발명은 상술한 목적을 달성하기 위하여, 본 발명인 효모성분추출물을 이용한 탈모치료제는 막걸리 효모 및 맥주 효모 중 적어도 어느 하나이상의 효모성분을 포함하여 구성되는 것을 특징으로 한다.In order to achieve the above-mentioned object, the present invention is characterized in that the hair loss treatment agent using the yeast component extract of the present invention comprises at least one yeast component from a rice wine yeast and a brewer's yeast.

또한, 본 발명인 효모성분추출물을 이용한 탈모치료제 제조방법은 효모를 배양액 내에서 발효시키는 1단계; 상기 효모와 배양액을 원심분리하여 상등액을 제거한 후 효모성분과 침전물을 분리하는 제 2단계; 상기 2단계의 효모성분을 증류수로 세척하여 수용성 냄새성분을 제거하는 제 3단계; 상기 3단계의 효모성분을 원심분리하여 상등액을 제거하는 제 4단계; 상기 4단계의 효모성분을 알콜로 세척하여 알콜 용해성 냄새성분을 제거하는 제 5단계; 상기 5단계의 효모성분을 원심분리하여 상등액을 제거하는 제 6단계; 상기 6단계의 효모성분을 증류수에 분산시켜 세포를 팽창시키는 제 7단계; 상기 7단계의 효모성분의 세포를 파쇄하여 증류수 내에 효모세포성분과 파쇄산물을 확산시키는 제 8단계; 상기 제 8단계의 증류수를 원심분리하여 비수용성 침전물을 제거한 후 수용성 상등액을 수거하는 제 9단계; 상기 수용성 상등액을 멸균화하여 부패 가능성이 있는 미생물을 제거하는 제 10단계; 상기 제 10단계의 수용성 상등액을 냉동보관 또는 동결건조하여 효모성분추출물을 제조하는 제 11단계;를 포함하는 것을 특징으로 한다.In addition, the method of manufacturing a therapeutic agent for alopecia using the yeast extract of the present invention comprises the steps of: 1) fermenting yeast in a culture solution; A second step of separating the yeast component and the precipitate after the supernatant is removed by centrifuging the yeast and the culture solution; A third step of washing the yeast component of the second step with distilled water to remove the water-soluble odor component; A fourth step of removing the supernatant by centrifuging the yeast component of step 3; A fifth step of washing the yeast component of step 4 with alcohol to remove the alcohol soluble odor component; A sixth step of centrifuging the yeast component of step 5 to remove the supernatant; A seventh step of expanding the cells by dispersing the yeast component of step 6 in distilled water; An eighth step of disrupting cells of the yeast component in step 7 to diffuse the yeast cell component and the crushed product in distilled water; Separating the water-soluble supernatant after removing the non-aqueous precipitate by centrifuging the distilled water in the eighth step; A step 10 of sterilizing the aqueous supernatant to remove microorganisms that may be decayed; And an eleventh step of preparing the yeast component extract by freezing or freeze-drying the aqueous supernatant of step 10).

본 발명인 효모성분추출물을 이용한 탈모치료제는 다음과 같은 효과가 있다.The hair loss treatment agent using the yeast component extract of the present invention has the following effects.

막걸리 효모 또는 맥주 효모를 이용하여 제조한 효모성분추출물을 두피에 도포함으로써 효모 성분 내 풍부한 영양분이 발모를 촉진하고 탈모를 방지하는 효과가 있다.By applying the yeast component extract prepared by using the rice wine yeast or brewer's yeast to the scalp, the nutrients rich in the yeast ingredient promote the hair growth and prevent hair loss.

또한, 효모성분추출물을 추출하는 공정에서 냄새 성분과 침전물을 제거하여 소비자의 기호도를 높이고, 추출물 내의 미생물을 제거함으로써 부패되지 않는 탈모치료제를 제공하는 효과가 있다.In addition, in the step of extracting the yeast component extract, the odor component and the precipitate are removed to increase the preference of the consumers, and the microorganisms in the extract are removed, thereby providing a therapeutic agent for depilation of hair that is not spoiled.

도 1은 본 발명의 효모성분추출물을 이용한 탈모치료제 제조방법을 보여주는 순서도.
도 2는 본 발명의 탈모치료제를 쥐 1에게 도포하기 전 촬영한 사진.
도 3은 본 발명의 탈모치료제를 쥐 1에게 6주 간 도포한 후에 촬영한 사진.
도 4는 본 발명의 탈모치료제를 쥐 2에게 도포하기 전 촬영한 사진.
도 5은 본 발명의 탈모치료제를 쥐 2에게 6주 간 도포한 후에 촬영한 사진.
도 6은 본 발명의 탈모치료제를 실험원 1에게 도포하기 전 촬영한 사진이다.
도 7은 본 발명의 탈모치료제를 실험원 1에게 6개월 간 도포한 후에 촬영한 사진.
도 8는 본 발명의 탈모치료제를 실험원 2에게 도포하기 전 촬영한 사진.
도 9은 본 발명의 탈모치료제를 실험원 2에게 6개월 간 도포한 후에 촬영한 사진.
1 is a flow chart showing a method for preparing a hair loss therapeutic agent using a yeast component extract of the present invention.
Fig. 2 is a photograph taken before application of the hair loss remedy of the present invention to mouse 1. Fig.
FIG. 3 is a photograph of the hair loss remedy of the present invention after being applied to mouse 1 for 6 weeks.
Fig. 4 is a photograph taken before application of the hair loss remedy of the present invention to mouse 2. Fig.
FIG. 5 is a photograph of the hair loss remedy of the present invention after being applied to mouse 2 for 6 weeks.
Fig. 6 is a photograph taken before application of the hair loss treatment agent of the present invention to Experimental Circle 1. Fig.
FIG. 7 is a photograph of the hair loss remedy of the present invention after being applied to Experiment circle 1 for 6 months.
FIG. 8 is a photograph taken before application of the hair loss treatment agent of the present invention to Experiment circle 2. FIG.
FIG. 9 is a photograph of the hair loss remedy of the present invention taken after the applicant 2 was applied for 6 months.

본 발명에 의한 효모성분추출물을 이용한 탈모치료제는 막걸리 효모 및 맥주 효모 중 적어도 어느 하나이상의 효모성분을 포함하여 구성되는 것을 특징으로 한다.The anti-depressant agent using the yeast component extract according to the present invention is characterized in that it comprises at least one yeast component from the rice wine yeast and the brewer's yeast.

하기에서는 이러한 효모성분추출물을 이용한 탈모치료제의 제조방법을 도면과 실시예를 이용하여 설명한다.
Hereinafter, a method for producing a hair loss therapeutic agent using the yeast component extract will be described with reference to drawings and Examples.

<효모성분추출물을 이용한 탈모치료제 제조방법>&Lt; Preparation method of hair loss therapeutic agent using yeast component extract >

도 1은 본 발명의 효모성분추출물을 이용한 탈모치료제 제조방법을 보여주는 순서도이다.
FIG. 1 is a flow chart showing a method of manufacturing a hair loss therapeutic agent using the yeast component extract of the present invention.

먼저, 제 1단계(S101)에서는 효모를 배양액 내에서 발효시킨다. 구체적으로, 맥주 및 막걸리 중 적어도 어느 하나이상에서 추출한 효모를 배양액 내에서 발효시킨다.First, in a first step (S101), the yeast is fermented in a culture solution. Specifically, the yeast extracted from at least one of beer and makgeolli is fermented in a culture solution.

다음으로, 제 2단계(S102)에서는 상기 효모와 배양액을 원심분리하여 상등액을 제거한 후 효모성분과 침전물을 분리한다. 구체적으로, 상기 발효시킨 효모를 수득하기 위하여 원심분리하여 상등액을 제거한 후 효모성분과 침전물을 분리하여 효모성분을 수득한다.Next, in the second step (S102), the yeast and the culture are centrifuged to remove the supernatant, and then the yeast component and the precipitate are separated. Specifically, the fermented yeast is centrifuged to remove the supernatant, and the yeast component and the precipitate are separated from each other to obtain a yeast component.

다음으로, 제 3단계(S103)에서는 수용성 냄새성분을 제거하기 위하여 상기 2단계의 효모성분을 증류수로 세척한다. 구체적으로, 상기 2단계에서 수득한 효모성분을 증류수로 1 내지 3회 세척한다. 증류수를 이용한 세척 작업을 거치지 않을 경우 효모성분 내에 수용성 냄새성분을 충분히 녹이지 못하며, 3회를 초과하여 세척할 경우 작업의 효율성을 해칠 수 있으므로 1 내지 3회 세척하는 것이 바람직하다.Next, in the third step (S103), the yeast component of the second step is washed with distilled water to remove the water-soluble odor component. Specifically, the yeast component obtained in step 2 is washed with distilled water one to three times. If the cleaning operation using distilled water is not performed, the water soluble odor component can not be sufficiently dissolved in the yeast component. If the washing operation is performed more than 3 times, the efficiency of the operation may be deteriorated.

다음으로, 제 4단계(S104)에서는 상기 3단계의 효모성분을 원심분리하여 상등액을 제거한다. 구체적으로, 상기 3단계의 효모성분을 원심분리하여 수용성 냄새 성분을 분리, 제거 한다..Next, in the fourth step (S104), the yeast components in the above three stages are centrifuged to remove the supernatant. Specifically, the yeast component from the three steps is centrifuged to separate and remove the water-soluble odor component.

다음으로, 제 5단계(S105)에서는 알콜용해성 냄새성분을 제거하기 위하여 상기 4단계의 효모성분을 알콜로 세척한다. 구체적으로, 상기 4단계의 효모성분 내에 포함되어 있는 알콜 용해성 냄새 성분을 제거하기 위하여 알콜로 세척한다.Next, in the fifth step (S105), the yeast component in the step 4 is washed with alcohol to remove the alcohol soluble odor component. Specifically, the alcohol-soluble odor component contained in the yeast component of step 4 is washed with alcohol.

또한, 알콜은 삼투능력으로 세균 표면의 막을 뚫고, 세균 내부로 들어가 세균의 생명기초인 단백질을 응고시키는 역할을 하여 세균을 제거한다. In addition, the alcohol penetrates the membrane of the bacterial surface with the osmotic power, enters the germs, and serves to coagulate the protein, which is the life basis of the germ, to remove the bacteria.

일반적으로 사용하는 알콜을 에탄올(Ethyl alcohol)로 70% 농도의 알콜을 사용한다. 이는 알콜의 농도가 70%를 초과할 경우 세균의 단백질을 응고시키는 능력은 매우 좋으나, 순간적으로 세균 표면의 단백질을 모두 응고시켜 세균의 외벽에 단단한 막을 형성시키므로 세균의 내부까지 알콜이 침투하는 것을 방해한다. 또한, 알콜의 농도가 70% 미만일 경우 세균의 단백질을 응고시키는 능력이 저하되어 완전한 세균의 제거가 어려우므로 70% 농도의 알콜을 사용하는 것이 바람직하다.Generally used alcohol is 70% alcohol with ethanol. If the concentration of alcohol exceeds 70%, the ability of the bacteria to coagulate the protein is very good. However, since the proteins on the surface of the bacteria are instantaneously coagulated to form a hard film on the outer wall of the bacteria, the alcohol is prevented from penetrating into the inside of the bacteria do. When the concentration of alcohol is less than 70%, it is difficult to completely remove bacteria because the ability of the bacteria to coagulate the protein is lowered. Therefore, it is preferable to use alcohol at a concentration of 70%.

다음으로, 제 6단계(S106)에서는 상기 5단계의 효모성분을 원심분리하여 상등액을 제거한다. 구체적으로, 상기 알콜로 세척한 효모성분을 원심분리하여 알콜 용해성 냄새 성분을 분리, 제거한다.Next, in the sixth step (S106), the yeast component in the fifth step is centrifuged to remove the supernatant. Specifically, the yeast component washed with the alcohol is centrifuged to separate and remove the alcohol-soluble odor component.

다음으로, 제 7단계(S107)에서는 상기 6단계의 효모성분을 증류수에 분산시켜 세포를 팽창시킨다. 구체적으로, 상기 효모성분을 증류수에 분산시켜 삼투압에 의해 세포를 팽창시킨다.Next, in a seventh step (S107), the yeast component of the sixth step is dispersed in distilled water to expand the cells. Specifically, the yeast component is dispersed in distilled water, and the cells are expanded by osmotic pressure.

다음으로, 제 8단계(S108)에서는 상기 7단계의 효모성분의 세포를 파쇄하여 증류수 내에 효모세포성분과 파쇄산물을 확산시킨다. 구체적으로, 팽창된 세포를 초음파, 마이크로 플루다이저, 유리비드, 프렌치 프레스 중 적어도 어느 하나 이상으로 파쇄하여 증류수 내에 효모세포성분과 파쇄산물이 확산되도록 한다.Next, in the eighth step (S108), the cells of the yeast component in the seventh step are disrupted to diffuse the yeast cell component and the crushed product in the distilled water. Specifically, the expanded cells are disrupted by at least one of an ultrasonic wave, a microfluidizer, a glass bead, and a French press so that the yeast cell component and the crushed product are diffused in the distilled water.

상기 파쇄 과정 시 효모 세포 내 유효 구성성분만을 선택적으로 추출할 수 있다. 즉, 상기 과정에서 침전물 및 부유물을 사전에 제거한 후 팽창 과정을 거친 세포를 파쇄함으로써 효모 세포 내의 유효 구성성분만을 선택적으로 추출할 수 있다.Only the effective constituents in yeast cells can be selectively extracted during the crushing process. That is, it is possible to selectively extract only effective components in yeast cells by disrupting cells that have undergone the expansion process after previously removing precipitates and suspensions in the above process.

다음으로, 제 9단계(S109)에서는 상기 제 8단계의 증류수를 원심분리하여 비수용성 침전물을 제거한 후 수용성 상등액을 수거한다. 구체적으로, 상기 효모세포성분과 파쇄산물이 확산된 증류수를 원심분리한 후 아래에 침전된 비수용성 침전물을 제거하여 수용성 상등액을 수거한다.Next, in the ninth step (S109), the distilled water in the eighth step is centrifuged to remove the non-aqueous precipitate, and the aqueous supernatant is collected. Specifically, the distilled water in which the yeast cell component and the crushed product are diffused is centrifuged, and then the non-aqueous precipitate precipitated below is removed to collect the aqueous supernatant.

다음으로, 제 10단계(S110)에서는 상기 수용성 상등액을 멸균화한다. 구체적으로, 상기 수용성 상등액 내의 부패 가능성이 있는 미생물을 제거하기 위하여 오토클레이브를 이용하여 멸균화한다.Next, in the tenth step (S110), the aqueous supernatant is sterilized. Specifically, sterilization is carried out using an autoclave in order to remove microorganisms which may be spoilable in the aqueous supernatant.

다음으로, 제 11단계(S111)에서는 상기 제 10단계의 수용성 상등액을 냉동보관 또는 동결건조하여 효모성분추출물을 제조한다. 구체적으로, 상기 멸균한 수용성 상등액을 냉동보관하여 액체형태의 효모성분추출물을 제조하거나 동결 건조하여 분말형태의 효모성분추출물을 제조한다.
Next, in the eleventh step (S111), the aqueous soluble supernatant of the tenth step is frozen or lyophilized to prepare a yeast component extract. Specifically, the sterilized aqueous supernatant is frozen and stored to prepare a liquid yeast component extract or lyophilized to prepare a powdery yeast component extract.

상기 효모성분추출물을 직접 두피에 도포함으로써 발모촉진 및 탈모 방지 효과를 나타내는 탈모치료제로서의 역할을 할 수 있다.
The yeast component extract can be directly applied to the scalp to serve as a hair loss treatment agent showing hair growth enhancement and hair loss prevention effect.

<탈모치료제 효과 입증 실험><Demonstration effect of hair loss treatment>

하기에서는 상기 본 발명의 효모성분추출물을 이용한 탈모치료제의 발모 촉진 및 탈모 방지 효과에 대한 품질검사를 위해 임상실험을 실시하고 실험한 내용을 도면을 참고하여 설명한다.In the following, clinical experiments are performed and quality tests for hair growth promotion and hair loss prevention effects of the hair loss treatment agent using the yeast component extract of the present invention are described with reference to the drawings.

실험은 쥐와 탈모 질환을 앓고 있는 실험원을 실험대상으로 각각 2회씩 진행하였으며, 탈모치료제를 도포하기 전 사진을 촬영한 후 탈모치료제를 일정기간 도포하고 도포부위를 재촬영하여 모발의 상태를 비교하여 그 결과를 아래와 같이 나타내었다.The experiment was conducted two times in each experimental group with the mouse and the hair loss disease. The photographs were taken before applying the hair loss treatment agent, and the hair loss treatment agent was applied for a certain period of time and the area of the hair was re- The results are shown below.

먼저, 본 발명의 탈모치료제를 쥐 1에게 실험한 결과이다.First, the result of an experiment on mouse 1 for the hair loss treatment agent of the present invention.

도 2는 본 발명의 탈모치료제를 쥐 1에게 도포하기 전 촬영한 사진이다.Fig. 2 is a photograph taken before applying the depilatory remedy of the present invention to mouse 1. Fig.

도 3은 본 발명의 탈모치료제를 쥐 1에게 6주 간 도포한 후에 촬영한 사진이다.FIG. 3 is a photograph of the hair loss remedy of the present invention after being applied to mouse 1 for 6 weeks.

도 2와 도 3을 비교한 결과 모발치료제를 도포한 쥐의 배부분에 검은 털이 다량 증가함을 육안으로 알 수 있었다.As a result of comparing FIG. 2 and FIG. 3, it can be seen visually that black hair increases in the abdomen portion of the mouse treated with hair treatment agent.

다음으로, 본 발명의 탈모치료제를 쥐 2에게 실험한 결과이다.Next, the result of an experiment on the mouse 2 for the hair loss treatment agent of the present invention.

도 4는 본 발명의 탈모치료제를 쥐 2에게 도포하기 전 촬영한 사진이다.FIG. 4 is a photograph taken before application of the hair loss treatment agent of the present invention to mouse 2. FIG.

도 5은 본 발명의 탈모치료제를 쥐 2에게 6주 간 도포한 후에 촬영한 사진이다.FIG. 5 is a photograph of the hair loss remedy of the present invention after being applied to mouse 2 for 6 weeks.

도 4와 도 5을 비교한 결과 모발치료제를 도포한 쥐의 배부분에 검은 털이 다량 증가함을 육안으로 알 수 있었다.As a result of comparison between FIG. 4 and FIG. 5, it was visually recognized that the black hair increased in the abdomen portion of the rats coated with the hair treatment agent.

다음으로, 본 발명의 탈모치료제를 실험원 1에게 실험한 결과이다.Next, the result of an experiment for the inventive hair loss treatment agent of Experimental Circle 1 is shown.

도 6은 본 발명의 탈모치료제를 실험원 1에게 도포하기 전 촬영한 사진이다.Fig. 6 is a photograph taken before application of the hair loss treatment agent of the present invention to Experimental Circle 1. Fig.

도 7은 본 발명의 탈모치료제를 실험원 1에게 6개월 간 도포한 후에 촬영한 사진이다.Fig. 7 is a photograph taken after applying the hair loss treatment agent of the present invention to Experiment circle 1 for 6 months.

도 6와 도 7을 비교한 결과 모발치료제를 도포한 두피부분에 모발의 수와 길이가 눈에 띄게 증가한 것을 알 수 있었다.As a result of comparing FIG. 6 and FIG. 7, it can be seen that the number and length of the hair in the scalp portion coated with the hair treatment agent were remarkably increased.

다음으로, 본 발명의 탈모치료제를 실험원 2에게 실험한 결과이다.Next, the result of an experiment on the hair loss treatment agent of the present invention to Experiment circle 2.

도 8는 본 발명의 탈모치료제를 실험원 2에게 도포하기 전 촬영한 사진이다.FIG. 8 is a photograph taken before applying the hair loss treatment agent of the present invention to the experimental circle 2.

도 9은 본 발명의 탈모치료제를 실험원 2에게 6개월 간 도포한 후에 촬영한 사진이다.Fig. 9 is a photograph of the hair loss remedy of the present invention after being applied to Experiment circle 2 for 6 months.

도 8와 도 9을 비교한 결과 모발치료제를 도포한 두피부분에 모발의 수와 길이가 눈에 띄게 증가한 것을 알 수 있었다.As a result of comparing FIG. 8 and FIG. 9, it can be seen that the number and length of hair in the scalp portion coated with the hair treatment agent are remarkably increased.

따라서, 상기 도 2 내지 도 9를 참고하여 보면 상기 상술한 나타낸 바와 같이 본 발명의 탈모치료제가 발모 촉진 및 탈모 방지 효과를 포함하는 것을 알 수 있다.2 to 9, it can be seen that the hair loss treatment agent of the present invention includes hair growth promoting and hair loss prevention effects as described above.

S101. 효모를 배양액 내에서 발효시키는 1단계
S102. 상기 효모와 배양액을 원심분리하여 상등액을 제거한 후 효모성분과 침전물을 분리하는 제 2단계
S103. 상기 2단계의 효모성분을 증류수로 세척하여 수용성 냄새성분을 제거하는 제 3단계
S104. 상기 3단계의 효모성분을 원심분리하여 상등액을 제거하는 제 4단계
S105. 상기 4단계의 효모성분을 알콜로 세척하여 알콜 용해성 냄새성분을 제거하는 제 5단계
S106. 상기 5단계의 효모성분을 원심분리하여 상등액을 제거하는 제 6단계
S107. 상기 6단계의 효모성분을 증류수에 분산시켜 세포를 팽창시키는 제 7단계
S108. 상기 7단계의 효모성분의 세포를 파쇄하여 증류수 내에 효모세포성분과 파쇄산물을 확산시키는 제 8단계
S109. 상기 제 8단계의 증류수를 원심분리하여 비수용성 침전물을 제거한 후 수용성 상등액을 수거하는 제 9단계
S110. 상기 수용성 상등액을 멸균화하여 부패 가능성이 있는 미생물을 제거하는 제 10단계
S111. 상기 제 10단계의 수용성 상등액을 냉동보관 또는 동결건조하여 효모성분추출물을 제조하는 제 11단계
S101. Step 1: fermenting the yeast in the culture medium
S102. A second step of separating the yeast component and the precipitate after the supernatant is removed by centrifuging the yeast and the culture solution,
S103. The third step of washing the yeast component of the second stage with distilled water to remove the water-soluble odor component
S104. The fourth step of removing the supernatant by centrifuging the yeast component in the third step
S105. The fifth step of washing the yeast component with the alcohol to remove the alcohol soluble odor component
S106. Step 6) of removing the supernatant by centrifuging the yeast component of step 5
S107. Step 7 in which the yeast component of step 6 is dispersed in distilled water to expand the cells
S108. Step 8 of spreading the yeast cell component and the crushed product in the distilled water by crushing the cells of the yeast component in the step 7,
S109. The ninth step is to centrifuge the distilled water to remove the non-aqueous precipitate, and then collect the aqueous supernatant.
S110. Tenth step of sterilizing the water-soluble supernatant to remove microorganisms that may be decayed
S111. Step 11) of preparing the yeast component extract by freezing or lyophilizing the aqueous supernatant of step 10)

Claims (4)

막걸리 효모 및 맥주 효모 중 적어도 어느 하나이상의 효모성분을 포함하여 구성되는 것을 특징으로 하는 효모성분추출물을 이용한 탈모치료제Wherein the yeast extract is at least one of yeast extract, yeast extract, yeast extract, yeast extract, yeast extract, 효모를 배양액 내에서 발효시키는 1단계;
상기 효모와 배양액을 원심분리하여 상등액을 제거한 후 효모성분과 침전물을 분리하는 제 2단계;
상기 2단계의 효모성분을 증류수로 세척하여 수용성 냄새성분을 제거하는 제 3단계;
상기 3단계의 효모성분을 원심분리하여 상등액을 제거하는 제 4단계;
상기 4단계의 효모성분을 알콜로 세척하여 알콜 용해성 냄새성분을 제거하는 제 5단계;
상기 5단계의 효모성분을 원심분리하여 상등액을 제거하는 제 6단계;
상기 6단계의 효모성분을 증류수에 분산시켜 세포를 팽창시키는 제 7단계;
상기 7단계의 효모성분의 세포를 파쇄하여 증류수 내에 효모세포성분과 파쇄산물을 확산시키는 제 8단계;
상기 제 8단계의 증류수를 원심분리하여 비수용성 침전물을 제거한 후 수용성 상등액을 수거하는 제 9단계;
상기 수용성 상등액을 멸균화하여 부패 가능성이 있는 미생물을 제거하는 제 10단계;
상기 제 10단계의 수용성 상등액을 냉동보관 또는 동결건조하여 효모성분추출물을 제조하는 제 11단계;를 포함하는 것을 특징으로 하는 효모성분추출물을 이용한 탈모치료제 제조방법
A step of fermenting yeast in a culture solution;
A second step of separating the yeast component and the precipitate after the supernatant is removed by centrifuging the yeast and the culture solution;
A third step of washing the yeast component of the second step with distilled water to remove the water-soluble odor component;
A fourth step of removing the supernatant by centrifuging the yeast component of step 3;
A fifth step of washing the yeast component of step 4 with alcohol to remove the alcohol soluble odor component;
A sixth step of centrifuging the yeast component of step 5 to remove the supernatant;
A seventh step of expanding the cells by dispersing the yeast component of step 6 in distilled water;
An eighth step of disrupting cells of the yeast component in step 7 to diffuse the yeast cell component and the crushed product in distilled water;
Separating the water-soluble supernatant after removing the non-aqueous precipitate by centrifuging the distilled water in the eighth step;
A step 10 of sterilizing the aqueous supernatant to remove microorganisms that may be decayed;
And a step of preparing a yeast component extract by freezing or freeze-drying the aqueous soluble supernatant of step 10).
제 2항에 있어서,
상기 제 5단계에서 알콜의 세척은,
농도 70%의 알콜을 이용하여 1 내지 3회 세척하는 것을 특징으로 하는 효모성분추출물을 이용한 탈모치료제 제조방법
3. The method of claim 2,
In the fifth step,
A method for preparing a hair loss therapeutic agent using a yeast component extract characterized by washing the hair with 1 to 3 times of an alcohol at a concentration of 70%
제 2항에 있어서,
상기 제 8단계에서의 세포의 파쇄는 초음파 파쇄기, 마이크로 플루다이저, 유리비드, 프렌치 프레스 중 적어도 어느 하나 이상으로 실시하는 것을 특징으로 하는 효모성분추출물을 이용한 탈모치료제 제조방법
3. The method of claim 2,
Wherein the cell breaking in the eighth step is carried out using at least one of an ultrasonic wave crusher, a microfluidizer, a glass bead, and a French press.
KR1020140053609A 2014-05-02 2014-05-02 A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof KR20150126215A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140053609A KR20150126215A (en) 2014-05-02 2014-05-02 A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140053609A KR20150126215A (en) 2014-05-02 2014-05-02 A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020160111092A Division KR20160106034A (en) 2016-08-30 2016-08-30 A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof

Publications (1)

Publication Number Publication Date
KR20150126215A true KR20150126215A (en) 2015-11-11

Family

ID=54605691

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140053609A KR20150126215A (en) 2014-05-02 2014-05-02 A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof

Country Status (1)

Country Link
KR (1) KR20150126215A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200118516A (en) 2019-04-04 2020-10-16 주식회사 비알팜 Composition for preventing hair loss or promoting hair growth
EP3711769A4 (en) * 2017-11-17 2021-11-24 Shiseido Co., Ltd. Ve-cadherin expression promoting agent and/or integrin 5 expression promoting agent

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3711769A4 (en) * 2017-11-17 2021-11-24 Shiseido Co., Ltd. Ve-cadherin expression promoting agent and/or integrin 5 expression promoting agent
US11311585B2 (en) 2017-11-17 2022-04-26 Shiseido Company, Ltd. VE-cadherin expression promoting agent and/or integrin α5 expression promoting agent
KR20200118516A (en) 2019-04-04 2020-10-16 주식회사 비알팜 Composition for preventing hair loss or promoting hair growth

Similar Documents

Publication Publication Date Title
JP6541888B2 (en) Method of producing functional cosmetics with improved wrinkles
KR102268324B1 (en) A topical composition comprising small RNA lichen extract and cosmetic care method for reducing skin signs of aging
JP6117456B1 (en) Wrinkle improving composition containing placenta-derived component
US9284359B2 (en) Method for mass preparation of proteoglycan
CN104825343A (en) Cosmetic composition containing fragments of biological cellulose membrane and method for producing same
KR100752623B1 (en) The manufacturing method of natural hair-restorer by using microorganism cultivation process and product thereof
CN106309280A (en) Rhizoma Zingiberis Recens extract and preparation method and application thereof
WO2009008656A2 (en) A soap composition for atopic dermatitis containing fermented extract of xanthium strumarium l. and preparation method thereof
KR20160106034A (en) A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof
KR20150126215A (en) A Pharmaceutical Agent For Treatment Of Alopecia Containing Yeast Constutuent Extract And The Manufacturing Method Thereof
CN113316448A (en) Rosa multiflora wood extract
CN104323948A (en) Freckle-removing compound essential oil
WO2018207810A1 (en) Method for producing amnion-derived raw material, method for producing cosmetic, and method for producing health food
CN106821935B (en) Method for extracting antibacterial composition from limulus reagent waste to prepare cosmetics
KR20150126530A (en) A Pharmaceutical Agent For Treatment Of Skin Diseases Containing Yeast Constutuent Extract And The Manufacturing Method Thereof
CN107412077A (en) It is a kind of it is sun-proof repair skin olive growing leaves it is ultraviolet stress submerged fermentation extract preparation method
KR101806007B1 (en) Manufacturing method of cosmetic composition containing nano particle natural materials and cosmetic composition manufactured by the same
CN105358165A (en) Pentosidine production inhibitor
CN102465151B (en) Ceramide and/or glucose ceramide produce the manufacture method of accelerator
KR102376994B1 (en) Hard Shampoo Soap containing Panax ginseng flower extracts and Manufacturing Method Using Thereof
KR20160122379A (en) Manufacture method of fermented complex using dongchimi materials and cosmetic composition using by the method and cosmetic comprising the cosmetic composition
CN110787122A (en) Camellia seed oil skin cream and preparation method thereof
TW201429411A (en) Method of combining pressure and enzyme to extract hydrolysate of non-animal-derived composition
KR102649731B1 (en) Method for producing bioactive material using blood and its application
JP7378217B2 (en) Cornflower fermented liquid and its manufacturing method, and cosmetics

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
A107 Divisional application of patent